Total planned funding: $662,412,239
Clear active filters
Chemonics International
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
Allocations
Countries/Regions
| Nigeria | $171,717,160 |
| Zambia | $105,763,123 |
| Uganda | $77,227,955 |
| Tanzania | $67,758,236 |
| Mozambique | $64,025,409 |
| Democratic Republic of the Congo | $26,762,919 |
| Zimbabwe | $20,943,970 |
| Haiti | $20,857,613 |
| Rwanda | $18,471,760 |
| Cameroon | $13,298,493 |
| Ethiopia | $12,732,083 |
| Côte d'Ivoire | $12,119,352 |
| South Africa | $8,242,059 |
| Western Hemisphere Region | $7,512,526 |
| Eswatini | $5,777,326 |
| Malawi | $5,750,410 |
| West Africa Region | $5,461,164 |
| Asia Regional Program | $4,135,000 |
| Namibia | $3,494,144 |
| Burundi | $3,303,618 |
| Lesotho | $2,742,370 |
| Vietnam | $1,998,530 |
| Angola | $1,370,256 |
| Kenya | $563,237 |
| enumerations.Philippines | $358,416 |
| Botswana | $25,110 |
Organizational Types
| Private Contractor | $662,412,239 |
Program Areas
| Treatment | $546,834,166 |
| Care | $51,122,955 |
| Governance and Systems | $30,948,296 |
| Prevention | $30,262,598 |
| Testing | $3,244,224 |
Budget Codes
| HTXD: Treatment: ARV Drugs | $370,505,121 |
| HTXS: Treatment: Adult Treatment | $158,393,979 |
| CIRC: Biomedical Prevention: Voluntary Medical Male Circumcision | $24,726,282 |
| OHSS: Health Systems Strengthening | $22,223,886 |
| HVTB: Care: TB/HIV | $20,374,450 |
| PDTX: Treatment: Pediatric Treatment | $17,935,066 |
| PDCS: Care: Pediatric Care and Support | $13,193,920 |
| HBHC: Care: Adult Care and Support | $13,154,585 |
| HLAB: Laboratory Infrastructure | $6,280,022 |
| HKID: Care: Orphans and Vulnerable Children | $4,400,000 |
| HVOP: Sexual Prevention: Other Sexual Prevention | $4,378,420 |
| HVCT: Testing: HIV Testing and Counseling | $3,244,224 |
| HVSI: Strategic Information | $2,444,388 |
| HVAB: Sexual Prevention: Abstinence/Be Faithful | $511,764 |
| MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $479,367 |
| IDUP: Prevention: Injecting and Non-Injecting Drug Use | $166,765 |
| HMIN: Biomedical Prevention: Injection Safety | $0 |